| Literature DB >> 17936624 |
Paul Galatsis1, Koji Yamagata, John A Wendt, Cleo J Connolly, John W Mickelson, Jared B J Milbank, Susan E Bove, Christopher S Knauer, Rachel M Brooker, Corinne E Augelli-Szafran, Roy D Schwarz, Jack J Kinsora, Kenneth S Kilgore.
Abstract
We describe three novel regioisomeric series of aryl naphthyridine analogs, which are potent antagonists of the Class III GPCR mGlu5 receptor. The synthesis and in vitro and in vivo pharmacological activities of these analogs are discussed.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17936624 DOI: 10.1016/j.bmcl.2007.09.083
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823